Teresa Byrne

Teresa Byrne is an experienced clinical research executive with more than 20 years of pharmaceutical industry experience from the research bench to the clinic. She has experience in both large pharmaceutical companies as well as in smaller biotech companies and clinical CROs. Teresa most recently led clinical development for Cersci Therapeutics, a small biotech company acquired by Acadia Pharmaceuticals. She has served in clinical operations leadership roles at Janssen Research & Development (a Johnson & Johnson company), Novartis Vaccines, and GlaxoSmithKline, and had held roles in global clinical trial management and clinical quality assurance. Teresa received a bachelor of arts degree in biology from Rutgers University, completed post-graduate work in clinical pharmacology at Thomas Jefferson University, and is a certified GCP auditor.